Skip to main content
. 2013 Mar 7;15(4):291–295. doi: 10.1111/jch.12082

Table 2.

Characteristics of Participants by Sex

Total (N=7032) Men (n=4073) Women (n=2959) P Value
Age, y 62.4±11.5 61.4±11.0 63.8±12.0 <.001
Body mass index, kg/m2 27.6±4.8 27.9±4.2 27.0±5.4 <.001
Waist circumference, cm 96.5±13.5 100.4±11.9 91.2±13.7 <.001
Current smoke, No. (%) 1058 (15.3) 760 (18.9) 298 (10.3) <.001
Systolic BP, mm Hg 154.2±12.5 154.0±12.4 154.6±12.7 .04
Diastolic BP, mm Hg 89.6±9.1 89.8±9.0 89.3±9.1 .03
Mean BP, mm Hg 111.1±8.6 111.2±8.6 111.1±8.7 .58
Pulse pressure, mm Hg 64.6±12.0 64.2±11.8 65.3±12.3 <.001
Heart rate, beats per s 75.6±8.8 75.5±8.9 75.8±8.7 .16
Plasma glucose, mmol/L 6.98±1.57 7.08±1.56 6.85±1.59 <.001
Hemoglobin A1c, % 6.74±1.08 6.71±1.04 6.77±1.13 .29
Total cholesterol, mmol/L 5.38±1.04 5.35±1.06 5.44±1.00 <.001
LDL cholesterol, mmol/L 3.31±0.94 3.29±0.97 3.33±0.91 .11
HDL cholesterol, mmol/L 1.39±0.42 1.33±0.41 1.46±0.43 <.001
Triglyceride, mmol/L 1.20±0.27 1.22±0.27 1.18±0.27 <.001
Diabetes mellitus, No. (%) 1572 (22.8) 955 (23.9) 617 (21.2) .008
Dyslipidemia, No. (%) 2007 (35.1) 1246 (37.8) 761 (31.4) <.001
Left ventricular hypertrophy, No. (%) 753 (12.0) 289 (12.7) 298 (11.1) .048
Coronary heart disease, No. (%) 519 (7.8) 387 (10.1) 132 (4.7) <.001
Microalbuminuria, No. (%) 399 (7.1) 257 (7.8) 142 (6.1) .01
Renal insufficiency, No. (%) 328 (4.9) 166 (4.3) 162 (5.8) .004
Antidiabetic therapy, No. (%) 1537 (22.1) 938 (23.3) 599 (20.5) .004
Antihyperlipidemic therapy, No. (%) 3110 (44.7) 1932 (47.9) 1178 (40.3) <.001
Antiplatelet therapy, No. (%) 1947 (28.1) 1247 (31.0) 700 (24.0) <.001

Abbreviations: BP, blood pressure; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein. Values are presented as mean±standard deviation or numbers (percentages). Disorders and therapy were defined by reading patients' medical document.